STEPHANIE MONTGOMERY: Open Payments
NPI 1467981787 · EASTON, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$934 in 46 payments from 20 companies in 2025. Trend: 2023 $1,005 · 2024 $913 · 2025 $934
Food & beverage: $934
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 6 | $91 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $88 |
| Lundbeck LLC | 4 | $88 |
| PFIZER INC. | 4 | $83 |
| Astellas Pharma US Inc | 3 | $80 |
| Exact Sciences Corporation | 3 | $68 |
| Merck Sharp & Dohme LLC | 3 | $68 |
| ABBVIE INC. | 3 | $60 |
| Lilly USA, LLC | 2 | $44 |
| Dexcom, Inc. | 2 | $39 |
Products named: REXULTI, Kerendia, Veozah, OTEZLA, The Cologuard Plus Collection Kit, GARDASIL 9, VRAYLAR, PREVNAR 20.
Industry payments across MD — which companies pay providers there.
